These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722. Winn M; von Geldern TW; Opgenorth TJ; Jae HS; Tasker AS; Boyd SA; Kester JA; Mantei RA; Bal R; Sorensen BK; Wu-Wong JR; Chiou WJ; Dixon DB; Novosad EI; Hernandez L; Marsh KC J Med Chem; 1996 Mar; 39(5):1039-48. PubMed ID: 8676339 [TBL] [Abstract][Full Text] [Related]
6. Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists. Riechers H; Albrecht HP; Amberg W; Baumann E; Bernard H; Böhm HJ; Klinge D; Kling A; Müller S; Raschack M; Unger L; Walker N; Wernet W J Med Chem; 1996 May; 39(11):2123-8. PubMed ID: 8667356 [TBL] [Abstract][Full Text] [Related]
7. Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists. Jae HS; Winn M; Dixon DB; Marsh KC; Nguyen B; Opgenorth TJ; von Geldern TW J Med Chem; 1997 Sep; 40(20):3217-27. PubMed ID: 9379441 [TBL] [Abstract][Full Text] [Related]
8. Selective endothelin A receptor antagonists. 3. Discovery and structure-activity relationships of a series of 4-phenoxybutanoic acid derivatives. Astles PC; Brealey C; Brown TJ; Facchini V; Handscombe C; Harris NV; McCarthy C; McLay IM; Porter B; Roach AG; Sargent C; Smith C; Walsh RJ J Med Chem; 1998 Jul; 41(15):2732-44. PubMed ID: 9667964 [TBL] [Abstract][Full Text] [Related]
9. A structure-activity study of a C-terminal endothelin analogue. Cassano E; Galoppini C; Giusti L; Hamdan M; Macchia M; Mazzoni MR; Menchini E; Pegoraro S; Rovero P Folia Biol (Praha); 1998; 44(1):11-4. PubMed ID: 10730869 [TBL] [Abstract][Full Text] [Related]
10. Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: in vitro studies. Wu-Wong JR; Dixon DB; Chiou WJ; Sorensen BK; Liu G; Jae HS; Tasker A; von Geldern TW; Winn M; Opgenorth TJ Clin Sci (Lond); 2002 Aug; 103 Suppl 48():107S-111S. PubMed ID: 12193066 [TBL] [Abstract][Full Text] [Related]
11. Selective endothelin A receptor antagonists. 4. Discovery and structure-activity relationships of stilbene acid and alcohol derivatives. Astles PC; Brown TJ; Halley F; Handscombe CM; Harris NV; McCarthy C; McLay IM; Lockey P; Majid T; Porter B; Roach AG; Smith C; Walsh R J Med Chem; 1998 Jul; 41(15):2745-53. PubMed ID: 9667965 [TBL] [Abstract][Full Text] [Related]
12. New non-peptide endothelin-A receptor antagonists: synthesis, biological properties, and structure-activity relationships of 5-(dimethylamino)-N-pyridyl-,-N-pyrimidinyl-,-N-pyridazinyl-, and -N-pyrazinyl-1-naphthalenesulfonamides. Bradbury RH; Bath C; Butlin RJ; Dennis M; Heys C; Hunt SJ; James R; Mortlock AA; Sumner NF; Tang EK; Telford B; Whiting E; Wilson C J Med Chem; 1997 Mar; 40(6):996-1004. PubMed ID: 9083490 [TBL] [Abstract][Full Text] [Related]
13. Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocycles. Walter M; Isensee K; Kottke T; Ligneau X; Camelin JC; Schwartz JC; Stark H Bioorg Med Chem Lett; 2010 Oct; 20(19):5883-6. PubMed ID: 20727744 [TBL] [Abstract][Full Text] [Related]
14. Development of CXCR3 antagonists. Part 2: Identification of 2-amino(4-piperidinyl)azoles as potent CXCR3 antagonists. Watson RJ; Allen DR; Birch HL; Chapman GA; Hannah DR; Knight RL; Meissner JW; Owen DA; Thomas EJ Bioorg Med Chem Lett; 2007 Dec; 17(24):6806-10. PubMed ID: 17964154 [TBL] [Abstract][Full Text] [Related]